General Information
Version
8.2
Revision date
2025-02-05
Product name
Sulindac
CAS No.
38194-50-2
REACH No
A
Emergency telephone
+56 2 2581 4934
Icons in SDS
Company Information
company name
Merck S.A
e-mail address of the competent person responsible for the Safety Data Sheet
atencionclientes@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H301, H317, H334, H361
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture Acute toxicity, (Category 3) H301: Toxic if swallowed Respiratory sensitization, H334: May cause allergy or asthma Category 1) symptoms or breathing difficulties if inhaled Skin sensitization, (Category 1) H317: May cause an allergic skin reaction Reproductive toxicity, (Category H361: Suspected of damaging fertility or the unborn child
Signal word
Danger
Hazard statements
H301 Toxic if swallowed. H317 May cause an allergic skin reaction. H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled. H361 Suspected of damaging fertility or the unborn child.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P261 Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P264 Wash skin thoroughly after handling. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P301 + P310 IF SWALLOWED: Immediately call a POISON CENTER/ doctor. P302 + P352 IF ON SKIN: Wash with plenty of water.
Supplemental label elements
none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Acute toxicity, (Category 3) H301: Toxic if swallowed. Respiratory sensitization, H334: May cause allergy or asthma (Category 1) symptoms or breathing difficulties if inhaled. Skin sensitization, (Category 1) H317: May cause an allergic skin reaction. Reproductive toxicity, (Category H361: Suspected of damaging fertility or 2) the unborn child.
